Spotlight on Policy, from the New Statesman  Por  arte de portada

Spotlight on Policy, from the New Statesman

De: The New Statesman
  • Resumen

  • Reporting on policy for the people who shape it and the business leaders it affects.

    Hosted on Acast. See acast.com/privacy for more information.

    The New Statesman
    Más Menos
activate_primeday_promo_in_buybox_DT
Episodios
  • The race to cervical cancer elimination | Sponsored
    Jun 29 2024

    Cervical cancer is the fourth most common cancer in women globally. It causes more than 800 deaths in the UK each year.

    Yet 99.8% of cervical cancer cases are entirely preventable. Regular screening and the introduction of the Human Papillomavirus (HPV) vaccination are helping to reduce the number of deaths. With smart policy and public health interventions NHS England have set 2040 as the target date for total elimination of cervical cancer.

    If that goal is to be met the issue of health inequality needs to be addressed; currently screening and vaccination rates vary between different regions, communities and socio-economic groups.

    So what needs to be done to share best practice and narrow these inequalities?

    In this episode of Spotlight on Policy, host Zoe Grunwald is joined by Emma Cerrone, Business Unit Director for Public Health & Vaccines at MSD; Dr Adeola Olaitan, Honorary Associate Professor at University College London and Honorary Consultant Gynaecological Oncologist at UCLH; and Gayathri Kumar, Senior Economist at OHE, the Office for Health Economics.

    This episode has been fully funded by MSD who, as sponsors, have reviewed and inputted to the final content. The report referenced by Office for Health Economics throughout this episode was fully funded by MSD. Ultimate editorial control for this episode and the OHE report rests solely with the New Statesman and the Office for Health Economics, respectively. MSD is one of the world’s leading pharmaceutical companies active in several key areas of global health, including immunisation and oncology.


    Hosted on Acast. See acast.com/privacy for more information.

    Más Menos
    22 m
  • "Heat or eat": how to help millions in fuel poverty | sponsored
    May 22 2024

    Fuel poverty is on the rise with millions of households in England having to choose whether to “heat or eat”.


    Last year, the Government estimated almost 9 million households could be classed as “fuel poor”. This means that, after housing costs, more than 10 per cent of their household income would be spent on heating.


    Covid supply disruptions and the war in Ukraine have contributed to the problem alongside the UK’s economic crisis.


    In this episode host Zoë Grünewald is joined by British Gas Energy Trust Chief Executive Jessica Taplin, Chief Executive of Citizens Advice Rhondda Cynon Taff, Ashley Comley and Chief Executive Officer of Bromley by Bow Centre, Ellen De Decker. They explore reasons for the sharp rise in fuel poverty, what’s being done to support those in need and what needs to change to ensure Government funding gets through to those who need it most.


    This New Statesman podcast episode is sponsored by The British Gas Energy Trust, an independent charitable trust funded solely by British Gas. The Trust offers financial support for vulnerable households and is celebrating its 20th anniversary this year.


    Hosted on Acast. See acast.com/privacy for more information.

    Más Menos
    25 m
  • How can life sciences investment make the UK healthier? | Sponsored
    May 8 2024

    The UK is on course for a huge rise in preventable illness. The Health Foundation charity predicts that by 2040, one in five adults will be living with a serious condition, such as cancer, dementia or heart disease. Meanwhile, economic activity is stagnating, with roughly 2.8 million people currently out of work due to ill health, according to the latest figures from the Office for National Statistics.


    Our world-leading life sciences sector has the capacity to help reverse this trend. In 2021 alone, it contributed £43.3bn to the UK economy, and supported 646,000 jobs. With the right investment, it could add an additional £68bn to GDP over the next 30 years, create 85,000 more jobs and result in a 40 per cent decrease in disease burden across the UK.


    This episode, in partnership with professional services firm PwC, explores how greater investment into vital disease areas such as cancer, obesity and immunology could make British society physically and financially healthier.


    Emma Haslett is joined by Chi Onwurah, the shadow minister for science, research and innovation; Dr Dan Mahoney, chair of the UK BioIndustry Association (BIA) and the government’s life sciences investment envoy; and Stephen Aherne, pharmaceutical and life sciences leader at PwC UK.


    If you enjoyed this podcast you can find more of Spotlight's policy reporting in our standalone Spotlight podcast feed, or at newstatesman.com/spotlight


    Hosted on Acast. See acast.com/privacy for more information.

    Más Menos
    33 m

Lo que los oyentes dicen sobre Spotlight on Policy, from the New Statesman

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.